DAVISON 2,4-D B 400 SELECTIVE HERBICIDE

Main information

  • Trade name:
  • DAVISON 2,4-D B 400 SELECTIVE HERBICIDE
  • Class:
  • AgChem
  • Medicine domain:
  • Plants
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • DAVISON 2,4-D B 400 SELECTIVE HERBICIDE
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • BARLEY - UNDERSOWN WITH CLOVER, LUCERNE | CLOVER PASTURE | CLOVER PASTURE SEEDLING | LUCERNE - ESTABLISHED | LUCERNE PASTURE SEE
  • Therapeutic area:
  • HERBICIDE
  • Therapeutic indications:
  • AMARANTH OR AMARANTHUS | ANNUAL BUTTERCUP | BATHURST BURR | BLACK BINDWEED | CALIFORNIAN BURR | CALIFORNIAN THISTLE | CAPE TULIP | CAPEWEED | CHARLOCK | DOCK | FAT HEN | HEDGE OR WILD MUSTARD | HOARY CRESS OR WHITEWEED | INDIAN HEDGE MUSTARD | MALLOW | MEXICAN OR PRICKLY POPPY | NOOGOORA BURR | PATERSON'S CURSE | PLANTAIN | PRINCE OF WALES FEATHER | SAFFRON THISTLE | SHEPHERD'S PURSE | SKELETON WEED | SPINY EMEX | STAGGER WEED | STINGING OR DWARF NETTLE | THORNAPPLE | THREE CORNERED JACK OR DOUBLEGEE | VARIEGATED THISTLE | WHITEFLOWER FUMITORY | WILD TURNIP | WIREWEED, KNOTWEED OR HOGWEED | AMARANTHUS CRUENTUS | AMARANTHUS POWELLII | AMARANTHUS VIRIDIS | ANNUAL BINDWEED | ANNUAL DWARF NETTLE | ANNUAL NETTLE | ARGEMONE OCHROLEUCA | BILDERDYKIA CONVOLVULUS | BLESSED THISTLE | BRASSICA CAMPESTRIS | BRASSICA KABER | BRASSICA RAPA SSP. SYLVESTRIS | BRASSICA RAPA VAR. SYLVESTRIS | BRASSICA SINAPISTRUM | BROADLEAF DOCK | BUCKWHEAT | BULL THISTLE | CABBAGE THISTLE | CANADA THISTLE | CARDUUS MARIANUS | CASTOR OIL (FAL

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Archived
  • Authorization number:
  • 31645
  • Last update:
  • 09-08-2016

7-9-2018

Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Montelukast Tablets USP, 10mg 30Ct. due to Product/Label Mix-Up

Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Montelukast Tablets USP, 10mg 30Ct. due to Product/Label Mix-Up

Camber Pharmaceuticals, Inc. is voluntarily recalling one single lot of Montelukast Sodium Tablets, USP 10mg, to the consumer level. This recall of one batch of Montelukast Sodium Tablets, USP 10mg, lot# MON17384 Exp. 12/31/2019, was prompted because a complaint of a sealed bottle labeled as Montelukast 10mg 30 ct found to contain 90 tablets of Losartan Potassium Tablets, USP 50mg

FDA - U.S. Food and Drug Administration

18-12-2018


Calcium chloride / glutamic acid / glutathione / histidine / lactobionic acid / magnesium chloride / mannitol / potassium chloride / sodium hydroxide: List of nationally authorised medicinal products - PSUSA/00010390/201801

Calcium chloride / glutamic acid / glutathione / histidine / lactobionic acid / magnesium chloride / mannitol / potassium chloride / sodium hydroxide: List of nationally authorised medicinal products - PSUSA/00010390/201801

Calcium chloride / glutamic acid / glutathione / histidine / lactobionic acid / magnesium chloride / mannitol / potassium chloride / sodium hydroxide: List of nationally authorised medicinal products - PSUSA/00010390/201801

Europe - EMA - European Medicines Agency

12-12-2018


Magnesium sulphate heptahydrate, sodium sulphate anhydrous, potassium sulphate: CMDh scientific conclusions and grounds for variation, amendments to the product information and timetable for the implementation - EMEA/H/N/PSR/S/0016

Magnesium sulphate heptahydrate, sodium sulphate anhydrous, potassium sulphate: CMDh scientific conclusions and grounds for variation, amendments to the product information and timetable for the implementation - EMEA/H/N/PSR/S/0016

Magnesium sulphate heptahydrate, sodium sulphate anhydrous, potassium sulphate: CMDh scientific conclusions and grounds for variation, amendments to the product information and timetable for the implementation - EMEA/H/N/PSR/S/0016

Europe - EMA - European Medicines Agency

12-12-2018


Magnesium sulphate heptahydrate, sodium sulphate anhydrous, potassium sulphate: List of nationally authorised medicinal products - EMEA/H/N/PSR/S/0016

Magnesium sulphate heptahydrate, sodium sulphate anhydrous, potassium sulphate: List of nationally authorised medicinal products - EMEA/H/N/PSR/S/0016

Magnesium sulphate heptahydrate, sodium sulphate anhydrous, potassium sulphate: List of nationally authorised medicinal products - EMEA/H/N/PSR/S/0016

Europe - EMA - European Medicines Agency

26-11-2018


Withdrawn application: HopGuard Gold, purified semi-solid extract from Humulus lupulus L. containing approximately 48% of beta acids as potassium salts, Date of withdrawal: 12/04/2018, Initial authorisation

Withdrawn application: HopGuard Gold, purified semi-solid extract from Humulus lupulus L. containing approximately 48% of beta acids as potassium salts, Date of withdrawal: 12/04/2018, Initial authorisation

Withdrawn application: HopGuard Gold, purified semi-solid extract from Humulus lupulus L. containing approximately 48% of beta acids as potassium salts, Date of withdrawal: 12/04/2018, Initial authorisation

Europe - EMA - European Medicines Agency

22-11-2018


Opinion/decision on a Paediatric investigation plan (PIP): Citric acid (as citric acid anhydrous) / sodium chloride / simeticone / macrogol 4000 / sodium citrate /sodium sulfate (as sodium sulfate anhydrous) / potassium chloride (PMF104), decision type:

Opinion/decision on a Paediatric investigation plan (PIP): Citric acid (as citric acid anhydrous) / sodium chloride / simeticone / macrogol 4000 / sodium citrate /sodium sulfate (as sodium sulfate anhydrous) / potassium chloride (PMF104), decision type:

Opinion/decision on a Paediatric investigation plan (PIP): Citric acid (as citric acid anhydrous) / sodium chloride / simeticone / macrogol 4000 / sodium citrate /sodium sulfate (as sodium sulfate anhydrous) / potassium chloride (PMF104), decision type: , therapeutic area: , PIP number: P/0223/2018

Europe - EMA - European Medicines Agency